Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex.

Wierońska JM, Kłak K, Pałucha A, Brański P, Pilc A.

Brain Res. 2007 Dec 12;1184:88-95. Epub 2007 Oct 13.

PMID:
17976546
2.
3.

Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus.

Wierońska JM, Legutko B, Dudys D, Pilc A.

Pharmacol Rep. 2008 Nov-Dec;60(6):844-55.

4.

Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc.

Nowak G, Schlegel-Zawadzka M.

Biol Trace Elem Res. 1999 Jan;67(1):85-92.

PMID:
10065601
5.

Alterations in serum and brain trace element levels after antidepressant treatment. Part II. Copper.

Schlegel-Zawadzka M, Nowak G.

Biol Trace Elem Res. 2000 Jan;73(1):37-45.

PMID:
10949967
6.

Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus.

Matrisciano F, Storto M, Ngomba RT, Cappuccio I, Caricasole A, Scaccianoce S, Riozzi B, Melchiorri D, Nicoletti F.

Neuropharmacology. 2002 Jun;42(8):1008-15.

PMID:
12128001
8.

Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus.

Smiałowska M, Szewczyk B, Brański P, Wierońska JM, Pałucha A, Bajkowska M, Pilc A.

Neuropharmacology. 2002 Jun;42(8):1016-23.

PMID:
12128002
11.

The activity of rat brain nitric oxide synthase following chronic antidepressant treatment.

Jopek R, Kata M, Nowak G.

Acta Pol Pharm. 1999 Jul-Aug;56(4):307-10.

12.

Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus.

Bajkowska M, Brański P, Smiałowska M, Pilc A.

Pol J Pharmacol. 1999 Nov-Dec;51(6):539-41.

PMID:
10817534
14.

Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.

Tatarczyńska E, Pałucha A, Szewczyk B, Chojnacka-Wójcik E, Wierońska J, Pilc A.

Pol J Pharmacol. 2002 Nov-Dec;54(6):707-10.

15.
16.

Activator protein-1 responsive to the group II metabotropic glutamate receptor subtype in association with intracellular calcium in cultured rat cortical neurons.

Sugiyama C, Nakamichi N, Ogura M, Honda E, Maeda S, Taniura H, Yoneda Y.

Neurochem Int. 2007 Dec;51(8):467-75. Epub 2007 May 10.

PMID:
17559977
17.

Comparison of the effects of antidepressant drugs on the level of cAMP in the rat striatum and nucleus accumbens septi.

Rogoz R, Dziedzicka-Wasylewska M.

Pol J Pharmacol. 1996 Sep-Oct;48(5):481-7.

PMID:
9112689
18.

Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.

Sairanen M, O'Leary OF, Knuuttila JE, Castrén E.

Neuroscience. 2007 Jan 5;144(1):368-74. Epub 2006 Oct 13.

PMID:
17049169
19.

Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.

Stachowicz K, Chojnacka-Wójcik E, Kłak K, Pilc A.

Pharmacol Rep. 2006 Nov-Dec;58(6):820-6.

20.

Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.

Wierońska JM, Szewczyk B, Pałucha A, Brański P, Zieba B, Smiałowska M.

Pharmacol Rep. 2005 Nov-Dec;57(6):734-43.

Supplemental Content

Support Center